PHARMACY BUSINESS PLAN

I. Executive Summary

Company Description

Hearthside Pharmacy (name chosen to evoke home-centered care) is a modern community retail pharmacy launched in 2026 operating in the U.S. outpatient pharmacy sector. We dispense prescriptions and deliver clinical pharmacy services: medication therapy management, immunizations, chronic-care medication synchronization, adherence coaching, and a curated wellness product assortment. We run a licensed pharmacy with on-site pharmacists and technicians, a private consultation room, same-day local delivery, and a point-of-care testing kiosk to support medication decisions. Our one-line pitch: community pharmacy that treats patients like family and medical partners.

We target local families, seniors on multiple chronic meds, and health-conscious adults in a fast-growing residential market. Short-term goals: reach 1,200 monthly prescriptions, convert 20% of patients to paid adherence programs, and achieve break-even within 18 months. Long-term goals: expand clinical revenue to 35% of sales, open a second location by 2030, and partner with two primary-care practices for coordinated care. What sets us apart: longer pharmacist-patient time, measurable adherence programs, and integrated delivery and home support that improve outcomes and retention.

Problem

Large chain pharmacies prioritize high-volume throughput over patient care, producing an impersonal, rushed experience where customers—especially families and seniors—cannot get one-on-one counseling, private consultations, or consistent relationships with pharmacists; this leads to medication errors, poor adherence, and higher downstream healthcare use.

Existing retail pharmacies lack private, accessible spaces and staff capacity for scheduled, relationship-driven consultations, so preventive care and chronic-disease management are fragmented and underserved; patients need a local pharmacy that provides time-driven, trust-based care. One sentence: Patients need trusted, time-driven pharmacy care, not hurried transactions.

Solution

Local residents face impersonal, high-volume pharmacy experiences that cause confusion, long waits, and poor chronic-care outcomes. Our solution converts the pharmacy into a community health hub that integrates prescription dispensing with Medication Therapy Management (MTM), medication synchronization, and adherence packaging, plus a curated wellness product selection. One sentence: we provide trusted, relationship-driven pharmacy care that simplifies medication use and supports whole-person health.

Core offering: dedicated one-on-one pharmacist consultations, comprehensive MTM reviews, synchronized refills, dose packaging for daily adherence, and a selected line of vitamins and natural remedies—delivered in an accessible, community-focused setting.

Mission Statement

Our mission is to empower our community to achieve optimal health through personalized care, expert guidance, and long-term, trust-based relationships. We commit to being the most reliable and accessible health resource in our neighborhood, going beyond transactions to support each patient’s unique wellness journey. We put patient needs first, deliver consistent clinical and service excellence, and build lasting local partnerships to improve community health.

Key Success Factors

Success depends on hitting conversion, repeat rates, margin mix, operational control, and deep local integration.

• Convert 38% of visitors to loyal customers by 2030 to drive scale and revenue predictability.
• Maintain 85% repeat customer rate to minimize acquisition cost and maximize lifetime value.
• Shift sales mix to high‑margin wellness supplements and clinical services to improve long‑term profitability.
• Control PBM fees and COGS to sustain a 34.89% ROE through tight procurement and reimbursement management.
• Leverage physician referrals and local health events to create a durable community-based competitive advantage.

Financial Summary

Brief financial snapshot for the 2026 U.S. launch showing rapid breakeven and scalable EBITDA growth.

Financial requirements: minimum cash reserve $647,000 (minimum cash month Jun-26); breakeven Jul-26; payback 17 months; expected IRR 13% and ROE 34.89%.

Overall outlook: modest first-year EBITDA with fast scale to multi-million EBITDA by year three and strong investor returns.

Funding Requirements

We require USD 902,000 to cover capital expenditures, initial inventory, and a minimum cash balance through the June 2026 cash trough to support our 2026 U.S. launch.